Creating novel treatments

for amyloid diseases

About ADRx

ADRx is advancing drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The ADRx team has developed  ADvantage, a novel drug discovery technology platform that  leverages our deep understanding of amyloid protein structure, aggregation and function. ADRx has employed its ADvantage technology to design and evolve novel compounds to address unmet medical needs in amyloid diseases. ADRx is a privately funded preclinical stage biotechnology company located in Thousand Oaks, California.

LINKS
CONTACT

info@adrxpharma.com

Tel: (805)-497-2379

515 Marin St., Suite 314

Thousand Oaks, CA 91360

  • White LinkedIn Icon

© 2019 by ADRx Inc.